MedPath

Outcomes in Minimally Invasive Versus Open Pancreaticoduodenectomy

Completed
Conditions
Pancreatic Disease
Interventions
Procedure: traditional pancreaticoduodenectomy
Procedure: minimally invasive pancreaticoduodenectomy
Registration Number
NCT02638818
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to evaluate the impact of the quality of life in patients undergoing the Whipple procedure (pancreaticoduodenectomy, PD) for pancreatic cancer. The Whipple procedure can be done by laparoscopic (small incisions) or an open procedure (large incision) to treat the patients cancer. The goal of this study is to see if there is any difference in quality of life between patients who undergo the laparoscopic or the open Whipple procedure. Surgical technique (minimally invasive versus open) will be at the discretion of the operating surgeon. Patients will not be randomized to a treatment arm.

A subset of these patients will also be asked to take part in a pre- and postoperative in-depth interview to explore the lived experiences of patients with resectable pancreatic cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • All patients scheduled for pancreaticoduodenectomy will be eligible for this study.
  • Subject must be at least 18 years of age and at least the minimum Age of Majority according to applicable State or Country Law.
  • Subject is a suitable surgical candidate, i.e. is able to undergo general anesthesia and PD for diagnosis of cancer
  • Subject is willing and able to cooperate with survey participation.
  • Subject has been informed of the study procedures and the treatment and has signed an informed consent form
Exclusion Criteria

• Subject is not a suitable candidate for PD

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
traditional whippletraditional pancreaticoduodenectomySurgical technique (minimally invasive versus open) will be at the discretion of the operating surgeon. Patients will not be randomized to a treatment arm.
minimally invasive whippleminimally invasive pancreaticoduodenectomySurgical technique (minimally invasive vs open) will be at the discretion of the operating surgeon. Patients will not be randomized to a treatment arm.
Primary Outcome Measures
NameTimeMethod
Change in quality of life, as measured by FACT-Hep scoreBaseline (before surgery), at hospital discharge (up to approximately 14 days), at first clinic visit (within 2 weeks after discharge), 3 months

The summed overall FACT-Hep score (0-180) will be the primary outcome.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath